Goldman Sachs Added Elan Corp. plc (ELN) to its Conviction Buy List
More News related to ELN
- Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Elan Corporation plc to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Be
- Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit Against Elan Corporation plc
- El Nino Ventures Inc. makes significant Copper/Cobalt discovery (29 meters at 2.82% Cu and 0.34% Co) in the Democratic Republic of Congo
- Elan Announces Dates for Upcoming Corporate Events
- Post-Hoc Analysis of TYSABRI Demonstrates Sustained Improvement in Functional Outcomes in Multiple Sclerosis Patients
More News related to Analyst Comments
- AIG Issues Statement in Response to NY AG Cuomo's Letter to the AIG Board of Directors
- Valspar (VAL) Renews Share Repurchase Authorization of 4M Shares
- BioMarin Pharma (BMRN) Announces Results from Phase 2a Study of 6R-BH4
- Autodesk (ADSK) Completes Acquisition of Electrical Computer-Aided Design ECSCAD Technology
- Air Products (APD) Announces Recent Investments in Europe
Goldman Sachs added Elan Corp. plc (NYSE: ELN) to its Conviction Buy List.
Elan Corporation, plc operates as a neuroscience-based biotechnology company primarily in Ireland and the United States.
Related Categories
Analyst CommentsStocks Mentioned
-1.05Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
